Skip to content

A clinical study of Vibhitaka phala churna in the management of Tamaka Shwasa,Bronchial asthma.

To Evaluate The Clinical Effect Of Vibhitaka Phala Churna In The Management Of Tamaka Shwash W.S.R. To Bronchial Asthama - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082803
Enrollment
30
Registered
2025-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

None listed

Sponsors

Shree Swaminarayan Ayurvedic College, kalol,
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient fulfilling the diagnostic criteria. 2.Patient having intermittent, mild persistence or moderate persistent type of asthma. 3.Newly diagnosed patients of asthma less than 01 year. 4.Patient having PEFR percentage more than 40 percent.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating woman. 2.Patients suffering from pathological condition like hypertension, carcinoma, left ventricular hypertrophy (LVH), ischemic heart disease (IHD), tuberculosis and diabetes mellitus. 3.Patients having status asthmatics and acute severe exacerbation of asthma or severe persistent asthma were excluded in the present study.

Design outcomes

Primary

MeasureTime frame
1.Relief in the symptoms of tamaka shwasa. 2.To assess the effect of Vibhitaka Phala Churna with Madhu in the management of Tamaka shwasa,bronchial asthma. Timepoint: 28 days.

Secondary

MeasureTime frame
1.To study the etiopathogenesis,symptomatology and progress of the disease i.e. Nidan panchaka and predominance of dosha according to ayurvedic classics as well as modern medical science.Timepoint: 28 days.

Countries

India

Contacts

Public ContactSandipkumar R Rajput

Shree Swaminarayan Ayurvedic College,kalol

pravinkharadi321@gmail.com9978136650

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026